J&J to discontinue E.coli vaccine candidate study-March 2024-www.financetom.com

J&J to discontinue E.coli vaccine candidate study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

J&J to discontinue E.coli vaccine candidate study

Feb 13, 2025 3:26 AM

Feb 13 (Reuters) - Johnson & Johnson ( JNJ ) on Thursday

said it will discontinue a late-stage study of an experimental

E.coli vaccine that it was developing in partnership with Sanofi

The drugmaker said its decision was based on the

recommendation of an independent committee that found the

vaccine candidate may not be sufficiently effective.

Previous page： Docebo Partnering With Intercap to Offer Free E-learning to Charities in the U.S. and Canada Next page： Clarivate Insider Sold Shares Worth $420,000, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Docebo Partnering With Intercap to Offer Free E-learning to Charities in the U.S. and Canada

Oct 17, 2024

04:25 PM EDT, 10/17/2024 (MT Newswires) -- Docebo ( DCBO ) said Thursday afternoon it is partnering with Intercap Equity's Intercap Impact unit to create Open World Learning (OWL), a free e-learning platform for small charities and nonprofits in Canada and the United States. The on-line education company said the initiative aims to eliminate the cost barriers to e-learning that...

Clarivate Insider Sold Shares Worth $420,000, According to a Recent SEC Filing

Oct 17, 2024

04:23 PM EDT, 10/17/2024 (MT Newswires) -- Bar Veinstein, President, Academia & Government, on October 15, 2024, sold 60,000 shares in Clarivate ( CLVT ) for $420,000. Following the Form 4 filing with the SEC, Veinstein has control over a total of 916,583 shares of the company, with 916,583 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1764046/000176404624000136/xslF345X05/wk-form4_1729196349.xml ...

US says China making far more goods than it needs to overtake global markets

Oct 17, 2024

WASHINGTON (Reuters) - Data showed that China had a significant overcapacity and was making far more goods than it needs in order to overtake global markets, White House official Daleep Singh said on Thursday. Singh added China had amassed a growing amount of market power and was using it in way that gave it economic and geopolitical leverage. So that's...

Intuitive Surgical Q3 Non-GAAP EPS, Revenue Increase; Shares Rise After Hours

Oct 17, 2024

04:19 PM EDT, 10/17/2024 (MT Newswires) -- Intuitive Surgical ( ISRG ) reported Q3 non-GAAP earnings Thursday of $1.84 per diluted share, up from $1.46 a year earlier. Analysts polled by Capital IQ expected $1.64. Revenue for the quarter ended Sept. 30 was $2.04 billion, up from $1.74 billion a year earlier. Analysts surveyed by Capital IQ expected $2.01 billion....